Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies

Autor: Syrogiannouli, L., Wildisen, L., Meuwese, C., Bauer, D.C., Cappola, A.R., Gussekloo, J., Elzen, W.P.J. den, Trompet, S., Westendorp, R.G.J., Jukema, J.W., Ferrucci, L., Ceresini, G., Asvold, B.O., Chaker, L., Peeters, R.P., Imaizumi, M., Ohishi, W., Vaes, B., Volzke, H., Sgarbi, J.A., Walsh, J.P., Dullaart, R.P.F., Bakker, S.J.L., Iacoviello, M., Rodondi, N., Giovane, C. del, Thyroid Studies Collaboration

Publikováno v: Syrogiannouli, L, Wildisen, L, Meuwese, C, Bauer, D C, Cappola, A R, Gussekloo, J, den Elzen, W P J, Trompet, S, Westendorp, R G J, Jukema, J W, Ferrucci, L, Ceresini, G, Åsvold, B O, Chaker, L, Peeters, R P, Imaizumi, M, Ohishi, W, Vaes, B, Völzke, H, Sgarbi, J A, Walsh, J P, Dullaart, R P F, Bakker, S J L, Iacoviello, M, Rodondi, N, Del Giovane, C & for the Thyroid Studies Collaboration 2022, ' Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies ', Frontiers in Psychiatry, vol. 13, 774251 . https://doi.org/10.3389/fpsyt.2022.774251
Frontiers in Psychiatry, 13:774251. Frontiers Media S.A.
Frontiers in Psychiatry, 13. FRONTIERS MEDIA SA
Frontiers in psychiatry, 13:774251. Frontiers Media S.A.
Frontiers in Psychiatry
Syrogiannouli, Lamprini; Wildisen, Lea; Meuwese, Christiaan; Bauer, Douglas C; Cappola, Anne R; Gussekloo, Jacobijn; den Elzen, Wendy P J; Trompet, Stella; Westendorp, Rudi G J; Jukema, J Wouter; Ferrucci, Luigi; Ceresini, Graziano; Åsvold, Bjørn O; Chaker, Layal; Peeters, Robin P; Imaizumi, Misa; Ohishi, Waka; Vaes, Bert; Völzke, Henry; Sgarbi, Josè A; ... (2022). Incorporating Baseline Outcome Data in Individual Participant Data Meta-Analysis of Non-randomized Studies. Frontiers in psychiatry, 13, p. 774251. Frontiers 10.3389/fpsyt.2022.774251

BackgroundIn non-randomized studies (NRSs) where a continuous outcome variable (e.g., depressive symptoms) is assessed at baseline and follow-up, it is common to observe imbalance of the baseline values between the treatment/exposure group and contro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02b1de7df207bb7b90ca2e4eb699a77
https://hdl.handle.net/11370/7e81497e-bb14-4f8c-80a8-b91e01641bcd

Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans

Autor: Nakanishi, S., Yamane, K., Ohishi, W., Nakashima, R., Yoneda, M., Nojima, H., Watanabe, H., Kohno, N.

Publikováno v: In Diabetes Research and Clinical Practice 2008 81(3):381-385

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection.

Autor: Miki, D.^1,2,3, Ohishi, W.^3,4, Ochi, H.^1,2,3, Hayes, C. N.^1,2,3, Abe, H.^1,2,3, Tsuge, M.^3,5, Imamura, M.^2,3, Kamatani, N.⁶, Nakamura, Y.⁷, Chayama, K.^1,2,3

Publikováno v: Journal of Viral Hepatitis. Feb2012, Vol. 19 Issue 2, pe126-e133. 8p. 4 Charts, 2 Graphs.